5-Chloro-1H-imidazo[4,5-b]pyridine(CAS: 52090-89-8)

5-Chloro-1H-imidazo[4,5-b]pyridine (CAS: 52090-89-8) should comply with the GHS classification, which categorizes it as a skin irritant and eye irritant. Additionally, it must adhere to REACH regulations in the EU, ensuring that its production, import, and use are documented and reported. In the USA, FDA and EPA regulations also apply, focusing on the safe handling, storage, and disposal of this compound to prevent environmental contamination.

Yes, there are alternative compounds that can serve similar functions in synthesis. For example, 4-Chloro-1H-imidazole and 1-Methyl-1H-imidazo[4,5-b]pyridine are common analogs. In terms of reagents, alternatives such as 2-Chloro-3-(imidazol-1-yl)pyridine can be used as less toxic substitutes. These alternatives are often chosen based on the specific requirements of the reaction and the desired product properties.

The market for 5-Chloro-1H-imidazo[4,5-b]pyridine (CAS: 52090-89-8) is growing due to its applications in pharmaceutical research, particularly as an intermediate in drug synthesis. Research trends indicate an increasing focus on its use in developing antifungal and antiparasitic agents. Additionally, there is a rising interest in studying its potential as a herbicide component. Market dynamics show a positive demand for this compound, driven by its unique chemical properties and emerging applications.

Waste containing 5-Chloro-1H-imidazo[4,5-b]pyridine (CAS: 52090-89-8) should be collected in appropriate containers and labeled with the correct hazardous waste symbol. The waste should be stored in a secure, ventilated area away from ignition sources. For disposal, it is recommended to use professional waste disposal services that specialize in hazardous chemicals. Proper incineration or chemical neutralization methods should be employed to ensure the compound is handled safely and environmentally responsibly, minimizing the risk of contamination and ensuring compliance with local and international regulations.